Skip to main content
ARS Home » Pacific West Area » Davis, California » Western Human Nutrition Research Center » Obesity and Metabolism Research » Research » Publications at this Location » Publication #384971

Research Project: Improving Public Health by Understanding Metabolic and Bio-Behavioral Effects of Following Recommendations in the Dietary Guidelines for Americans

Location: Obesity and Metabolism Research

Title: The mothers, infants, and lactation quality (MILQ) study: A multi-center collaboration

Author
item Allen, Lindsay - A
item HAMPEL, DANIELA - University Of California, Davis
item Shahab-Ferdows, Setti
item ANDERSSON, MARIA - University Hospital Zurich
item BARROS, ERICA - Universidade Federal Do Rio De Janeiro
item DOEL, ANDREW - King'S College
item ERIKSEN, KAMILLA - University Of Copenhagen
item CHRISTENSEN, SOPHIE HILARIO - University Of Copenhagen
item ISLAM, MUNIRUL - International Centre For Diarrhoeal Disease Research
item KAC, GILBERTO - Universidade Federal Do Rio Grande Do Norte (UFRN)
item KEYA, FARHANA - International Centre For Diarrhoeal Disease Research
item MICHAELSEN, KIM - University Of Copenhagen
item MUCCI, DANIELA - Universidade Federal Do Rio De Janeiro
item NJIE, FANTA - London School Of Hygiene & Tropical Medicine
item PEERSON, JANET - Eg Consulting (SELF-EMPLOYED)
item MOORE, SOPHIE - King'S College

Submitted to: Current Developments in Nutrition
Publication Type: Peer Reviewed Journal
Publication Acceptance Date: 9/7/2021
Publication Date: 9/20/2021
Citation: Allen, L.H., Hampel, D., Shahab-Ferdows, S., Andersson, M., Barros, E., Doel, A., Eriksen, K.G., Christensen, S., Islam, M., Kac, G., Keya, F.K., Michaelsen, K., Mucci, D., Njie, F., Peerson, J., Moore, S.E. 2021. The mothers, infants, and lactation quality (MILQ) study: A multi-center collaboration. Current Developments in Nutrition. 5(10). Article nzab116. https://doi.org/10.1093/cdn/nzab116.
DOI: https://doi.org/10.1093/cdn/nzab116

Interpretive Summary: Exclusive breastfeeding (EBF) is recommended by the World Health Organization (WHO) for infants’ first 6 months of life. Besides being the sole recommended nutrient source during this time, human milk is a crucial provider of nutrients for the next ˜200 days. However, there is little valid information on the actual nutrient concentrations, especially in the case of micronutrients (MN), due to sample collection and analytical limitations. No valid Reference Values (RVs) are available for the concentrations of nutrients in milk across lactation. Consequently, it is likely that inaccurate estimates of milk MN concentrations have been used to set recommendations for nutrient intakes of infants, young children, and lactating women. Further, we lack benchmarks against which to evaluate human milk quality (i.e. adequacy of nutrient content), or the need for, or effects of, nutrient interventions on milk MN. In this multi-center collaborative study, RVs will be established for human milk nutrients across the first 8.5 months of lactation. Well-nourished, unsupplemented lactating women in Bangladesh, Brazil, Denmark, and The Gambia (n = 250 per site) are recruited during the third trimester of pregnancy. Milk, blood, saliva, urine, and stool samples from mothers and infants are collected at three time periods (1-3.49, 3.5-5.99, 6.0-8.49 months of lactation) in an identical way across all sites. EBF is required for the first time period, predominantly breastfeeding (PBF) for the second and some breastfeeding for the third. At all three time periods, milk analyses include macronutrients, fat- and water-soluble vitamins, trace elements and other minerals, iodine, metabolomics, amino acids, human milk oligosaccharides, and bioactive peptides. Further, we measure breast milk volumes; maternal and infant diets, anthropometry, and morbidity; infant development; and at some sites, the maternal genome and the infant and maternal microbiome. We will present RVs as a range between the 5th (lowest) percentile and 95th (highest) percentile of values from the combined data across countries. Clinical trials.gov registration number: NCT03254329

Technical Abstract: Background: Exclusive breastfeeding (EBF) is the feeding practice recommended by the World Health Organization (WHO) for infants’ first 6 months of life. Besides being the sole recommended nutrient source during this time, human milk is a crucial provider of nutrients for the next ˜200 days. However, there is little valid information on the actual nutrient concentrations, especially in the case of micronutrients (MN), due to sample collection and analytical limitations. No valid Reference Values (RVs) are available for the concentrations of nutrients in milk across lactation. Consequently, it is likely that inaccurate estimates of milk MN concentrations have been used to set recommendations for nutrient intakes of infants, young children, and lactating women. Further, there are no RV benchmarks against which to evaluate human milk quality (i.e. adequacy of nutrient content), or the need for, or effects of, nutrient interventions on milk MN. Methods: In this multi-center collaborative study, RVs will be established for human milk nutrients across the first 8.5 months of lactation. Well-nourished, unsupplemented lactating women in Bangladesh, Brazil, Denmark, and The Gambia (n = 250 per site) are recruited during the third trimester of pregnancy. Milk, blood, saliva, urine, and stool samples from mothers and infants are collected at three time periods (1-3.49, 3.5-5.99, 6.0-8.49 months of lactation) in a systematic, identical way across all country sites. EBF is required for the first time period, predominantly breastfeeding (PBF) for the second and some breastfeeding for the third. At all three time periods, milk analyses include macronutrients, fat- and water-soluble vitamins, trace elements and other minerals, iodine, metabolomics, amino acids, human milk oligosaccharides, and bioactive peptides. Further, we measure breast milk volumes; maternal and infant diets, anthropometry, and morbidity; infant development; and at some sites, the maternal genome and the infant and maternal microbiome. Results: RVs will be constructed in a similar way to the WHO Child Growth Standards and the Intergrowth-21st Project. Clinical trials.gov registration number: NCT03254329